BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2296193)

  • 1. Relation of proliferative activity to survival in patients with gastric carcinoma.
    Tonemura Y; Kamata T; Ooyama S; Sugiyama K; Kimura H; Kosaka T; Yamaguchi A; Miyazaki I
    J Surg Oncol; 1990 Jan; 43(1):3-7. PubMed ID: 2296193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of proliferative activity to survival in patients with advanced gastric cancer.
    Yonemura Y; Kamata T; Ohoyama S; Matumoto H; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Anal Cell Pathol; 1991 Mar; 3(2):103-10. PubMed ID: 2025600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
    Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling.
    Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer; 1989 Oct; 64(8):1665-8. PubMed ID: 2790680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
    Yonemura Y; Miyazaki I
    Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of DNA ploidy and proliferative activity in human gastric cancer.
    Yonemura Y; Sugiyama K; Fujimura T; De Aretxabala X; Kamata T; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer; 1988 Oct; 62(8):1497-502. PubMed ID: 3167767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell proliferation in early gastric cancer: biological and clinical behavior.
    Dionigi P; Ferrari A; Jemos V; Luinetti O; Vai L; Guizzetti M; Ferrari C; Jemos K; Spada M; Mazzini G
    Hepatogastroenterology; 2004; 51(55):264-8. PubMed ID: 15011882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
    Yonemura Y; Kimura H; Fushida S; Tugawa K; Nakai Y; Kaji M; Fonseca L; Yamaguchi A; Miyazaki I
    Cancer; 1993 Apr; 71(8):2448-53. PubMed ID: 8095851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67.
    Yonemura Y; Ooyama S; Sugiyama K; Ninomiya I; Kamata T; Yamaguchi A; Matsumoto H; Miyazaki I
    Cancer; 1990 Mar; 65(5):1130-4. PubMed ID: 2406006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromodeoxyuridine labeling index in gastric cancer].
    Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1718-21. PubMed ID: 2480515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma].
    Yonemura Y; Sugiyama K; Kamata T; Fushida S; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1611-5. PubMed ID: 2849039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferative activity as a marker for lymph node metastases on early gastric cancers--in vitro bromodeoxyuridine labeling for clinical use].
    Ohyama S; Yonemura Y; Kamata T; Kosaka T; Yamaguchi A; Kouichi ; Miwa ; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):354-9. PubMed ID: 2359392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative prediction of gastric cancer development by in vitro labelling index of bromodeoxyuridine].
    Sugiyama K; Yonemura Y; Takamura H; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):796-8. PubMed ID: 8489287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
    Kang SM; Kim WH; Kim CW; Kim YI
    J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell kinetic study of human carcinomas using bromodeoxyuridine and immunohistochemistry].
    Kikuyama S
    Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):355-63. PubMed ID: 2770679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.
    Ohyama S; Yonemura Y; Miyazaki I
    Cancer; 1992 Jan; 69(2):314-21. PubMed ID: 1728362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.
    Yonemura Y; Ooyama S; Sugiyama K; Kamata T; De Aretxabala X; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer Res; 1990 Feb; 50(3):509-14. PubMed ID: 2297693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
    Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetic study of human carcinomas using bromodeoxyuridine.
    Kikuyama S; Kubota T; Watanabe M; Ishibiki K; Abe O
    Cell Tissue Kinet; 1988 Jan; 21(1):15-20. PubMed ID: 3056618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.